Skip to main content
. 2013 Mar;28(2):115–123. doi: 10.1089/cbr.2012.1268

FIG. 1.

FIG. 1.

Sensitivity of different non-small cell lung cancer (NSCLC) cell lines to Gefitinib. (A) The inhibitory effects of Gefitinib against different NSCLC cell lines. Tumor cells were seeded in 96-well plates and treated with different Gefitinib concentrations for 72 hours, and then cell viability was measured with CellTiter-Glo. (B) Caspase3/7 activity in different NSCLC cell lines after the treatment of Gefitinib. Tumor cells were seeded in 96-well plates and treated with Gefitinib at indicated concentration for 24 hours. The caspase3/7 activity was measured with a caspase3/7 luminescent assay kit Caspase-Glo™.